- Home
- BLNK vs ACOG Comparison
BLNK vs ACOG Comparison
Compare BLNK & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- ACOG
- Stock Information
- Founded
- BLNK 2009
- ACOG 2000
- Country
- BLNK United States
- ACOG Canada
- Employees
- BLNK 706
- ACOG N/A
- Industry
- BLNK Industrial Specialties
- ACOG
- Sector
- BLNK Consumer Discretionary
- ACOG
- Exchange
- BLNK Nasdaq
- ACOG Nasdaq
- Market Cap
- BLNK 103.7M
- ACOG 91.6M
- IPO Year
- BLNK N/A
- ACOG N/A
- Fundamental
- Price
- BLNK $1.03
- ACOG $6.28
- Analyst Decision
- BLNK Buy
- ACOG
- Analyst Count
- BLNK 8
- ACOG 0
- Target Price
- BLNK $5.24
- ACOG N/A
- AVG Volume (30 Days)
- BLNK 4.1M
- ACOG 101.6K
- Earning Date
- BLNK 03-13-2025
- ACOG 11-15-2024
- Dividend Yield
- BLNK N/A
- ACOG N/A
- EPS Growth
- BLNK N/A
- ACOG N/A
- EPS
- BLNK N/A
- ACOG N/A
- Revenue
- BLNK $138,728,000.00
- ACOG N/A
- Revenue This Year
- BLNK N/A
- ACOG N/A
- Revenue Next Year
- BLNK $22.16
- ACOG N/A
- P/E Ratio
- BLNK N/A
- ACOG N/A
- Revenue Growth
- BLNK 15.13
- ACOG N/A
- 52 Week Low
- BLNK $0.92
- ACOG $4.66
- 52 Week High
- BLNK $3.75
- ACOG $7.00
- Technical
- Relative Strength Index (RSI)
- BLNK 29.72
- ACOG N/A
- Support Level
- BLNK $0.92
- ACOG N/A
- Resistance Level
- BLNK $1.19
- ACOG N/A
- Average True Range (ATR)
- BLNK 0.07
- ACOG 0.00
- MACD
- BLNK 0.00
- ACOG 0.00
- Stochastic Oscillator
- BLNK 36.21
- ACOG 0.00
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.